- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 492920, 8 pages
doi:10.1155/2012/492920
Modulation of Immunity by Antiangiogenic Molecules in Cancer
1INSERM U970, Paris Cardiovascular Research Center (PARCC), Université Paris-Descartes, Sorbonne Paris Cité, 56 rue Leblanc, 75015 Paris, France
2Service d’Immunologie Biologique, Hôpital Européen Georges Pompidou, AP-HP, 75015 Paris, France
3Service d’Hépatogastro-Entérologie et d’Oncologie Digestive, Hôpital Européen Georges Pompidou, AP-HP, 75015 Paris, France
Received 27 July 2012; Accepted 10 December 2012
Academic Editor: W. Kast
Copyright © 2012 Magali Terme et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Magali Terme, Orianne Colussi, Elie Marcheteau, Corinne Tanchot, Eric Tartour, and Julien Taieb, “Modulation of Immunity by Antiangiogenic Molecules in Cancer,” Clinical and Developmental Immunology, vol. 2012, Article ID 492920, 8 pages, 2012. doi:10.1155/2012/492920